Oxygen Sparing Effect of Bacteriotherapy in COVID-19
Giancarlo Ceccarelli, Massimiliano Marazzato, Luigi Celani, Francesca Lombardi, Alessandra Piccirilli, Massimo Mancone, Vito Trinchieri, Francesco Pugliese, Claudio M Mastroianni, Gabriella D’ettorre
Nutrients, doi:10.3390/nu13082898
Background: We previously reported that severe COVID-19 patients had higher chances of survival and a reduced risk of developing respiratory failure when administered with the probiotic formulation SLAB51. This study aimed to investigate further bacteriotherapy mechanisms and how early they are activated. Methods: We performed an analysis on the blood oxygenation parameters collected in sixty-nine severe COVID-19 patients requiring non-invasive oxygen therapy and presenting a CT lung involvement ≥50%. Twenty-nine patients received low-molecular-weight heparin, azithromycin and Remdesivir. In addition, forty subjects received SLAB51. Blood gas analyses were performed before the beginning of treatments and at 24 h. Results: The patients receiving only standard therapy needed significantly increased oxygen amounts during the 24 h observation period. Furthermore, they presented lower blood levels of pO 2 , O 2 Hb and SaO 2 than the group also supplemented with oral bacteriotherapy. In vitro data suggest that SLAB51 can reduce nitric oxide synthesis in intestinal cells. Conclusions: SARS-CoV-2 infected patients may present lesions in the lungs compromising their gas exchange capability. The functionality of the organs essential for these patients' survival depends mainly on the levels of pO 2 , O 2 Hb and SaO 2 . SLAB51 contains enzymes that could reduce oxygen consumption in the intestine, making it available for the other organs.
Conflicts of Interest: The authors declare no conflict of interest.
References
Abruzzo, Vitali, Lombardi, Guerrini, Cinque et al., Mucoadhesive Buccal Films for Local Delivery of Lactobacillus brevis, Pharmaceutics,
doi:10.3390/pharmaceutics12030241Baud, Dimopoulou Agri, Gibson, Reid, Giannoni, Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic, Front. Public Health,
doi:10.3389/fpubh.2020.00186Bellan, Soddu, Balbo, Baricich, Zeppegno et al., Respiratory and Psychophysical Sequelae Among Patients with COVID-19 Four Months after Hospital Discharge, JAMA Netw. Open,
doi:10.1001/jamanetworkopen.2020.36142Ceccarelli, Borrazzo, Pinacchio, Santinelli, Innocenti et al., Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study, Front. Nutr
Core, R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing
D'ettorre, Ceccarelli, Marazzato, Campagna, Pinacchio et al., Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19, Front. Med,
doi:10.3389/fmed.2020.00389Giannoni, Baud, Agri, Gibson, Reid, Probiotics and COVID-19, Lancet Gastroenterol. Hepatol
Grimes, Khan, Badeaux, Rao, Rowlinson et al., Arginine depletion as a therapeutic approach for patients with COVID-19, Int J. Infect. Dis,
doi:10.1016/j.ijid.2020.10.100Ignarro, Nitric oxide as a unique signaling molecule in the vascular system: A historical overview, J. Physiol. Pharmacol
Izzo, Marra, Beneduce, Castello, Vallone et al., Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies, J. Clin. Oncol,
doi:10.1200/JCO.2004.11.120Lundquist, Artursson, Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues, Adv. Drug Deliv. Rev,
doi:10.1016/j.addr.2016.07.007Mach, Thimmesch, Pierce, Pierce, Consequences of hyperoxia and the toxicity of oxygen in the lung, Nurs Res. Pract,
doi:10.1155/2011/260482Palumbo, Lombardi, Augello, Giusti, Luzzi et al., NOS2 inhibitor 1400 W Induces Autophagic Flux and Influences Extracellular Vesicle Profile in Human Glioblastoma U87MG Cell Line, Int J. Mol. Sci,
doi:10.3390/ijms20123010Palumbo, Miconi, Cinque, Lombardi, La Torre et al., NOS2 expression in glioma cell lines and glioma primary cell cultures: Correlation with neurosphere generation and SOX-2 expression, Oncotarget,
doi:10.18632/oncotarget.16106Panaro, Carofiglio, Acquafredda, Cavallo, Cianciulli, Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells, Br. J. Nutr,
doi:10.1017/S0007114511007227Perrone, Belser, Wadford, Katz, Tumpey, Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice, J. Infect. Dis,
doi:10.1093/infdis/jit062Rabi, Al Zoubi, Kasasbeh, Salameh, Al-Nasser, SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far, Pathogens,
doi:10.3390/pathogens9030231Riccia, Bizzini, Perilli, Polimeni, Trinchieri et al., Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease, Oral Dis,
doi:10.1111/j.1601-0825.2006.01291.xSinghal, Shah, Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine, J. Biol. Chem,
doi:10.1074/jbc.REV120.011188Sundararaman, Ray, Ravindra, Halami, Role of probiotics to combat viral infections with emphasis on COVID-19, Appl Microbiol. Biotechnol,
doi:10.1007/s00253-020-10832-4Xu, Shi, Wang, Zhang, Huang et al., Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir Med,
doi:10.1016/S2213-2600(20)30076-XZuo, Zhang, Lui, Yeoh, Li et al., Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization, Gastroenterology,
doi:10.1053/j.gastro.2020.05.048
